ICON and ICHOM are creating the world’s first global healthcare outcomes benchmarking programm

821
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by the International Consortium for Health Outcomes Measurement (ICHOM) to advance value-based healthcare through the launch of a global healthcare outcomes benchmarking program called GLOBE. ICON is using its data management, data analytics and consultancy expertise to enable ICHOM to provide healthcare providers with a secure platform to share and compare high-quality, risk-adjusted health outcomes – the results of care that matter most to patients – that will lead to improvements in healthcare.

ICHOM is an independent, not-for-profit organisation founded in 2012 with the mission of unlocking the potential of value-based healthcare by facilitating the measurement and comparison of health outcomes. As a first step in realising its mission, ICHOM has worked with more than 400 leading clinicians, registry leaders, and patients worldwide to develop Standard Sets that provide a common language and approach to measuring outcomes at the condition level. The Standard Sets address 13 conditions that cover approximately 35% of the global disease burden.

 To date, over 70 healthcare provider systems and academic medical centres worldwide are implementing the Standard Sets to measure health outcomes. The GLOBE initiative will enable providers to compare their patients’ outcomes to those of their peers and identify opportunities to improve outcomes and/or lower costs while maintaining outcomes.